Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Income towards Parent Company: 2012-2025

Historic Income towards Parent Company for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $19.1 million.

  • Veracyte's Income towards Parent Company rose 26.33% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year increase of 426.92%. This contributed to the annual value of $24.1 million for FY2024, which is 132.44% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Income towards Parent Company is $19.1 million, which was up 2,052.76% from -$980,000 recorded in Q2 2025.
  • Veracyte's 5-year Income towards Parent Company high stood at $19.1 million for Q3 2025, and its period low was -$41.9 million during Q1 2021.
  • Over the past 3 years, Veracyte's median Income towards Parent Company value was -$980,000 (recorded in 2025), while the average stood at -$2.3 million.
  • As far as peak fluctuations go, Veracyte's Income towards Parent Company plummeted by 630.33% in 2023, and later soared by 477.04% in 2025.
  • Veracyte's Income towards Parent Company (Quarterly) stood at -$10.5 million in 2021, then soared by 63.16% to -$3.9 million in 2022, then slumped by 630.33% to -$28.3 million in 2023, then soared by 118.16% to $5.1 million in 2024, then grew by 26.33% to $19.1 million in 2025.
  • Its Income towards Parent Company was $19.1 million in Q3 2025, compared to -$980,000 in Q2 2025 and $7.0 million in Q1 2025.